Eliaz Therapeutics: Funding, Investors & Team (Oct 2026)
ETI have fostered a protected, novel clinical gadget that eliminates galectin-3 from human blood. The gadget eliminates both bound and free galectin-3 from the course, offering another treatment choice that is less obtrusive and has less aftereffects than different treatments. The single-use apheresis segment specifically eliminates Galectin-3 from the body. It contains an exclusive, profoundly powerful catching particle and is underlying an organization that medical clinics definitely know how to utilize.
Eliaz Therapeutics has raised $2.4M across 3 funding rounds on record, the most recent an Equity Crowdfunding of $40k announced in Jul 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Eliaz Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Eliaz Therapeutics Funding Rounds
Eliaz Therapeutics raised $1.7M in a Grant announced in Jun 2022.
3.9 years later, an undisclosed round of $640k was announced in May 2026.
2 months later, an Equity Crowdfunding of $40k was announced in Jul 2026.
Eliaz Therapeutics Investors
Eliaz Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Eliaz Therapeutics Funding Compared to Other Biotechnology Startups
Eliaz Therapeutics' latest round of $40k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Eliaz Therapeutics in Biotechnology and Santa Rosa
Companies Similar to Eliaz Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Eliaz Therapeutics Funding FAQs
What does Eliaz Therapeutics do?
ETI have fostered a protected, novel clinical gadget that eliminates galectin-3 from human blood. The gadget eliminates both bound and free galectin-3 from the course, offering another treatment choice that is less obtrusive and has less aftereffects than different treatments. The single-use apheresis segment specifically eliminates Galectin-3 from the body. It contains an exclusive, profoundly powerful catching particle and is underlying an organization that medical clinics definitely know how to utilize.
How much funding has Eliaz Therapeutics raised?
Eliaz Therapeutics has raised $2.4M across 3 rounds on record. The most recent is an Equity Crowdfunding of $40k announced in Jul 2026.
When did Eliaz Therapeutics last raise funding?
Eliaz Therapeutics' most recent funding round on record is an Equity Crowdfunding of $40k, announced in Jul 2026.
Who has invested in Eliaz Therapeutics?
Investors on record for Eliaz Therapeutics include National Institutes of Health.
Who founded Eliaz Therapeutics?
FundedIQ lists Isaac Eliaz (Founder) at Eliaz Therapeutics.
Where is Eliaz Therapeutics headquartered?
Eliaz Therapeutics is based in Santa Rosa, California, United States.
How many employees does Eliaz Therapeutics have?
Eliaz Therapeutics is in the 1-10 employee band.
When was Eliaz Therapeutics founded?
Eliaz Therapeutics was founded in 2015.
How does Eliaz Therapeutics' funding compare to other Biotechnology startups?
Eliaz Therapeutics' latest round of $40k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Eliaz Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Eliaz Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.